A complex interplay between genetic and environmental factors is thought to be involved in the etiology of Parkinson's disease (PD). A recent genome-wide association and interaction study (GWAIS) identified GRIN2A, which encodes an NMDA-glutamate-receptor subunit involved in brain's excitatory neurotransmission, as a PD genetic modifier in inverse association with caffeine intake. Here in, we attempted to replicate the reported association of a single nucleotide polymorphism, GRIN2A_rs4998386, and its interaction with caffeine intake with PD in patient-control study in an ethnically homogenous population in southeastern Sweden, as consistent and independent genetic association studies are the gold standard for the validation of genome-wide association studies. All the subjects (193 sporadic PD patients and 377 controls) were genotyped, and the caffeine intake data was obtained by questionnaire. We observed an association between rs4998386 and PD with odds ratio (OR) of 0.61, 95% confidence intervals (CI) of 0.39–0.96, p = 0.03, under a model excluding rare TT allele. There was also a strong significance in joint effects of gene and caffeine on PD risk (TC heavy caffeine vs. CC light caffeine: OR = 0.38, 95%CI = [0.20–0.70], p = 0.002) and gene-caffeine interaction (OR = 0.998, 95%CI = [0.991–0.999], p<0.001). Overall, our results are in support of the findings of the GWAIS and provided additional evidence indicating PD protective effects of coffee drinking/caffeine intake as well as the interaction with glutamate receptor genotypes.
References
[1]
Mata IF, Yearout D, Alvarez V, Coto E, de Mena L, et al. (2011) Replication of MAPT and SNCA, but not PARK16–18, as susceptibility genes for Parkinson's disease. Mov Disord 26: 819–823. doi: 10.1002/mds.23642
[2]
Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, et al. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74: 97–109. doi: 10.1111/j.1469-1809.2009.00560.x
[3]
Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, et al.. (2011) Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 7: e1002237. Available: http://www.plosgenetics.org/article/info？%3Adoi%2F10.1371%2Fjournal.pgen.1002237 Accessed 2014 January 15.
[4]
Larsson SC, Giovannucci E, Wolk A (2006) Coffee consumption and stomach cancer risk in a cohort of Swedish women. Int J Cancer 119: 2186–9. doi: 10.1002/ijc.22105
[5]
Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, et al. (2011) Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 43: 513–518. doi: 10.1038/ng.840
[6]
Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, et al.. (2011) NMDA receptor gene variations as modifiers in Huntington disease: a replication study. PLoS Curr 3: RRN1247. Available: http://currents.plos.org/hd/article/nmda？-receptor-gene-variations-as-modifiers-i？n-huntington-disease-a-replication-study？/. Accessed 2014 January 15.
[7]
Endele S, Rosenberger G, Geider K, Popp B, Tamer C, et al. (2010) Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 42: 1021–1026. doi: 10.1038/ng.677
[8]
Turic D, Langley K, Mills S, Stephens M, Lawson D, et al. (2004) Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol Psychiatry 9: 169–173. doi: 10.1038/sj.mp.4001387
[9]
Iwayama-Shigeno Y, Yamada K, Itokawa M, Toyota T, Meerabux JM, et al. (2005) Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia. Neurosci Lett 378: 102–105. doi: 10.1016/j.neulet.2004.12.013
[10]
Itokawa M, Yamada K, Iwayama-Shigeno Y, Ishitsuka Y, Detera-Wadleigh S, et al. (2003) Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans. Neurosci Lett 345: 53–56. doi: 10.1016/s0304-3940(03)00501-9
[11]
Higley MJ, Sabatini BL (2010) Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors. Nat Neurosci 13: 958–966. doi: 10.1038/nn.2592
[12]
Boeck CR, Kroth EH, Bronzatto MJ, Vendite D (2005) Adenosine receptors co-operate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity. Neuropharmacology 49: 17–24. doi: 10.1016/j.neuropharm.2005.01.024
[13]
Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 26 Suppl 1S1–58. doi: 10.1007/s10654-011-9581-6
[14]
Hallstr？m H, Wolk A, Glynn A, Micha？lsson K (2006) Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int 17: 1055–1064. doi: 10.1007/s00198-006-0109-y
[15]
Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, et al. (2012) Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 79: 659–667. doi: 10.1212/wnl.0b013e318264e353
[16]
Winkler S, K？nig IR, Lohmann-Hedrich K, Vieregge P, Kostic V, et al. (2007) Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease. Eur J Hum Genet 15: 1163–1168. doi: 10.1038/sj.ejhg.5201901
[17]
Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41: 1303–1307. doi: 10.1038/ng.485
[18]
Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7: 583–590. doi: 10.1016/s1474-4422(08)70117-0
[19]
Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, et al. (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 42: 781–785. doi: 10.1038/ng.642
[20]
Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M (2009) Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 16: 85–91. doi: 10.1016/j.jalz.2008.05.2136
[21]
Gelber RP, Petrovitch H, Masaki KH, Ross GW, White LR (2011) Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis 23: 607–615.
